TCP
PFE icon

Tourbillon Capital Partners’s Pfizer PFE Stock Holding History

Tourbillon Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,378,000
Closed -$207M – 77
2016
Q1 		$207M Sell
7,378,000
-232,331
-3% -$6.64M 4.46% 8
2015
Q4 		$233M Buy
+7,610,331
New +$239M 5.22% 3

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tourbillon Capital Partners's PFE Position: Q2 2016 in Review

Tourbillon Capital Partners sold out of Pfizer (PFE) in Q2 2016, closing a stake of 7,378,000 shares — an estimated $207M sold.

Tourbillon Capital Partners first reported a position in PFE in Q4 2015 and held it in 2 quarters. The position peaked at $233M in Q4 2015. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Tourbillon Capital Partners reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Tourbillon Capital Partners sold 7,378,000 Pfizer shares in Q2 2016, an estimated $207M.
  • Tourbillon Capital Partners first reported a position in Pfizer in Q4 2015 and held it in 2 quarters.
  • Tourbillon Capital Partners's Pfizer position peaked at $233M in Q4 2015.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Tourbillon Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.